470 likes | 758 Views
Hemophilia. Galila Zaher Consultant Hematologist MRCPath KAUH. Prevalence. World-wide occurs in all racial groups. Few decades ago, children with hemophilia had a significantly reduced life expectancy. Crippled with arthritis &joint deformity
E N D
Hemophilia Galila Zaher Consultant Hematologist MRCPath KAUH
Prevalence • World-wide occurs in all racial groups. • Few decades ago, children with hemophilia had a significantly reduced life expectancy. • Crippled with arthritis &joint deformity • Recent studies : increased life-expectancy • Now :face few limitations. • Normal schools, most jobs are open with full participation in society .
Hemophilia Statistics By Country • Country-specific prevalence statistics • Extrapolations of various prevalence rates against the populations • Calculation is automated and does not take into account differences across various countries • May be highly inaccurate and only give a general indication to actual prevalence CureResearch.com
Hemophilia Prevalence • Saudi Arabia :1,896 patients with Hemophilia • KFSH Riyadh >150 Patients • Department of Hematology Dammam :54patients • KAUH :40 patients • Lack of public awareness • Absence of national registry • Under- diagnosis
Hereditary Coagulation Factor Deficiencies In KFSH Riyadh • Patient number >159 • Hemophilia A:122 patients Hemophilia B:37 patients • Pediatrics :55 ,Adults: 102
Hereditary Coagulation Factor Deficiencies In Eastern Province • In a retrospective analysis 1991-97 • 54 patients • 42 hemophiliacs, 39 hemophilia A , 2 hemophilia B • 5 Saudi patients factor XIII deficiency • 7 patients von Willebrand disease. • Hemophilia B and von Willebrand disease was lower than expected East Mediterr Health J. 1999 Nov;5(6):1188-95.
Hereditary Coagulation Factor Deficiencies In KAUH • In a 5-year retrospective analysis (2000-2005)KAUH • 50 patients age 4-26 years • 44 inherited factor deficiency & 6 platelets defect • 21 hemophilia A , 12 hemophilia B • 2 patients factor V deficiency • 2 patients factor VII deficiency • One FX & FXII deficiency • 5 patients von Willebrand disease. • von Willebrand disease was lower than expected • Hemophilia B was higher than expected: Referral bias
Prevalence Of VWD • VWD commonest inherited bleeding disorder • Dammam 7/54 & KAUH 5/44 • Female patients presenting to gynecologist • Under- diagnosis : lack of lab support • VWF is an acute phase reactant
Diagnosis and Management • Base line coagulation screen • Mixing studies • Factor Assay • Bethesda assay • Factor Concentrate • DDAVP • Tranexamic acid • FFPs & Cryoprecipetate • Factor Concentrate
Report On The Universal DataCollection System Centers for Disease Control and Prevention &National Center for Infectious Diseases Atlanta, Georgia
Prevalence Of Hepatitis B Virus Exposure and Vaccination Status
Hepatitis B Virus Infection • The rate of exposure to HBV in congenital bleeding disorders 11.1% Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):256-7 • 26/44 not tested reflecting lack of written protocols • 18/44 tested and were negative reflecting the routine neonatal immunization program started 1990 in SA including HB vaccine
HCV Transmission • HCV major cause of virus-induced liver diseases • 1990, anti-HCV of blood donors became mandatory • Incidence of post-transfusion HCV < 1% • Improvements in HCV antibody assays: 1/106 • Hemophilia generated new susceptible populations
Hepatitis C Virus Antibodies Saudi Population • HCV is endemic in the Saudi population • Overall frequency of 5.3% • 5 X > reported from Western Europe and USA • Hemophiliacs. Seropositivity rate :78.6% Vox Sang. 1991;60(3):162-4
Case 1 • Patient name: M T • Sex: Male 2 years • Diagnosis: Hemophilia A at age of 7 m • Admission date: 3-11-2002 • Lethargy , vomiting & fever for 1 D • Tonic-clonic convulsions for 2 D
History & Examination • On/off painful joint swelling after minor injuries. • Not on regular treatment • Circumcision 6 m ago (FVIII). • Family history of hemophilia A ,thalassemia & SCA • Vitals normal • Neck rigidity • Neurological examination normal • Other systems examination
Investigations • Hb: 9.2g/dl WBC: 16.5X109 plt:509X109 • PT: 1.2 sec PTT: 69.2 sec • 50/50 immediate mix PTT 40.2 sec • 50/50 post- incubation mix :PTT 80 sec • Factor VIII level 2% • Inhibitor level :50 Bethesda units • CT scan brain : subdural hematoma
Management • Patient was started on factor VIII concentrate 8 hourly • Aiming x 100% x10 D • Neurosurgery consult : observe • Patient was improving clinically
Management • Patient was started on Malom Protocol • Cyclophosphamide 2 mg/kg/d • Prednisolone 1 mg/kg/d • Factor VIII stat 100 IU/kg Infusion 10 IU/kg/hr x3D
Hospital Course • Repeat CT scan : resolution of subdural hematoma • Patient was discharged on • Tegretol 50 mg PO BID • Cyclophosphamid 25 mg PO OD • Prednisolone 5 mg PO BID • F VIII conc 250 IU IV weekly
Follow-Up • Follow-up in OPD • Inhibitor screen at Nov 2003: Negative
Case 2 • 15 y old girl • Referred with history of PR bleeding . • History of salmonella infection. • PMH of ? 2 attacks of DVT (clinical suspicion).
Case Historycont • CBC : Hb 3.5 g/dl PLT 159X109/L. • Isolated prolonged APTT. • Mixing studies :NC. • LA screen :negative • Factor VIII level 2%. • PRBCs TX , FFP & FVIII concentrate.
Transfer To KAUH • Fresh PR bleeding & heavy menstrual period . • Febrile . • Bruises on anti-cubital fossa .
Investigations • Hb 7.5 g/dl & APTT 118 sec. • Mixing study :immediate & post incubation NC • Factor VIII level 2% & VWF level 80% • Bethesda assay> 500 IU. • LA screen &ACL Ab :negative . • Septic screen : negative. • Serology: HBSAg “R”,HBEAg positive • Family study FVIII level :normal
Admission Course • Upper GIT endoscopy “Hiatus Hernia”. • No blood TX. • Hb level 7.5 9.5 g/dl on iron supplementation.
Incidence • 1/1,000,000 annually. • Males = females. • 5th decade. • IgG 1-4 K or mixed . • Against A2 domain in 48%. • Or C2 domain : FVIII binding to VWF. Haemophilia 1998 Jul;4(4):558-63
Green D & Lechner K: Thrombosis and Haemostasis 45: 200-203 (1981)
Management • Clinical presentation. • Titer of the inhibitor. • Associated medical condition. • Likelihood of spontaneous remission . • Risk of toxicities of therapy . • Cost .
Management • Prednisolone 6 weeks • Regular F/U in OPD • Continuous search for underlying cause • CT chest ,abdomen & pelvis every year • Autoimmune profile every 6m • 3 years since diagnosis: Idiopathic Acquired Hemophilia
Dental Extraction • During F/U fracture wisdom tooth for extraction • Patient was admitted prior to extraction • FVII level >1% • Bethesda assay >500IU • Trial of FVIII conc under IVIG, no improvement • Recombinant FVII 90 micg ; No intra-operative nor post-operative bleed • Local fibrin glue to maintain local hemostasis
Case 3 • Patient name : H K • Known sever HA :bloody diarrhea Oct 2001 • Post circumcision bleed • Lf knee swelling post trauma • Family history :HA brother
Follow Up • Intra-muscular hematoma • Wasting of the Rt hand muscles post wrist bleed • Age :3 years :Inhibitor : 50 B IU • Rt knee hemarthrosis limited extension & flexion • Sever tongue bleed which required ICU admission • Inhibitor assay 2BU Low responder
Genetic Disorders &Impact On Health Care Delivery • No agreed-upon definitive cure with acceptable risk • Chronic nature requires lifelong medical attention • Expensive supportive and symptomatic therapy • Significant burden on the health care delivery system. el-Hazmi MA East Mediterr Health J. 1999 Nov;5(6):1104-13.
Hemophilia working Group in KAUH • Blood bank specialist • Pediatrician • Infectious disease specialist • Orthopedic surgeon • Dentist • Pharmacist • Hemophilia nurse • Social worker • Hematologist